Home NDC 83270-316 Nafcillin
Product NDC 83270-316
11-digit product format 832700316
Labeler code 83270
Product ID 83270-316_5d271b3d-8ac1-de0d-e063-6394a90a99f7
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Nafcillin
Dosage form INJECTION, POWDER, FOR SOLUTION
Route INTRAVENOUS
Labeler ONESOURCE SPECIALTY PHARMA LIMITED
Application ANDA203830
Marketing category ANDA
Marketing start 2026-10-12
Substance NAFCILLIN SODIUM
Active strength 10 g/1
Pharmacologic classes Penicillin-class Antibacterial [EPC], Penicillins [CS]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A203830-001 NAFCILLIN SODIUM NAFCILLIN SODIUM EQ 10GM BASE/VIAL INJECTABLE / INJECTION AP 2026-09-25
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A203830-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A203830-001 NAFCILLIN SODIUM EQ 10GM BASE/VIAL INJECTABLE / INJECTION AP 2026-09-25 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A203830-001 NAFCILLIN SODIUM EQ 10GM BASE/VIAL INJECTABLE / INJECTION AP 2026-09-25 c2088c7a36db…
Observed Orange Book normalized TE history# Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2026-11-14 07:37:17 2026-10 A203830-001 AP 1 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A203830-001 AP 1 c2088c7a36db…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Nafcillin
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength NAFCILLIN SODIUM 10 g/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 49G3001BCK Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 239189 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Nafcillin NAFCILLIN ONESOURCE SPECIALTY PHARMA LIMITED 5d271b9a-a667-0fd2-e063-6294a90a3b4a 2026-10-06 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 203830 application number: ANDA203830 ndc (product): 83270-316
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 83270-316-10 83270031610 10 INJECTION, POWDER, FOR SOLUTION in 1 CARTON (83270-316-10) 2026-10-12 No No Current